Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1626-1630

  Petrioli, Roberto ^a   Sabatino, Marianna ^a   Roviello, Franco ^a   Marrelli, Daniele ^a   Nastri, Giacomo ^a   Marsili, Stefania ^a   Correale, Pierpaolo ^a   Pozzessere, Daniele ^a   Messinese, Simona ^a   De Martino, Antonio ^a   Tani, Francesco ^a   Marzocca, Giuseppe ^a   Lorenzi, Marco ^a   Civitelli, Serenella ^a   Tanzini, Gabriello ^a   Pinto, Enrico ^a   Francini, Guido ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

5 Fluorouracil; Adjuvant chemotherapy; Etoposide; Gastric cancer

Indexed keywords

ETOPOSIDE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ANEMIA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DRUG TOLERABILITY; EVALUATION; FEMALE; FOLLOW UP; GASTRECTOMY; GASTROJEJUNOSTOMY; HUMAN; MALE; NAUSEA; NEUTROPENIA; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STOMACH CANCER; STOMATITIS; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; ETOPOSIDE; FEMALE; FLUOROURACIL; GASTRECTOMY; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; STOMACH NEOPLASMS;

EID: 25844514182     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parkin D, Pisani P, Ferlay J: Global Cancer Statistics. CA Cancer J Clin 1999; 49:33-64.
2. Diehl JT, Hermann RE, Cooperman AM, Hoerr SO: Gastric carcinoma. A ten year review. Ann Surg 1983; 198:9-12.
3. Middleton G, Cunningham D: Current options in the management of gastrointestinal cancer. Ann Oncol 1995; 6(Suppl 1):17-25.
4. O'Connell MJ: Current status of chemotherapy for advanced pancreatic and gastric carcinoma. J Clin Oncol 1985; 3:1032-1039.
5. The Gastrointestinal Tumor Study Group: Randomized study of combination chemotherapy in unresectable gastric cancer. Cancer 1984; 53:13-17.
6. Klein HO: Long-term results with FAMTX (5-fluorouracil, adriamycin, methotrexate) in advanced gastric cancer. Anti-cancer Res 1989; 9:1025-1026.
7. Findlay M, Cunningham D, Norman A, et al: A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF). Ann Oncol 1994; 5:609-616.
8. Coombes RC, Schein PS, Chilvers CE, et al: A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group. J Clin Oncol 1990; 8:1362-1369.
9. Allum WH, Hallissey MT, Kelly KA: Adjuvant chemotherapy in operable gastric cancer: 5 year follow-up of British Stomach Cancer Group trial. Lancet 1989; 18:571-574.
10. Estape J, Grau JJ, Lcobendas F, et al: Mitomycin C as an adjuvant treatment to resected gastric cancer: A 10-year follow-up. Ann Surg 1991; 213:219-221.
11. Wilke H, Preusser P, Fink U, et al: New developments in the treatment of gastric carcinoma. Sem Oncol 1990; 17(Suppl 2)61-70.
12. Wilke H, Preusser P, Fink U, et al: High dose folinic acid/etoposide/5-fluorouracil in advanced gastric cancer-a phase II study in elderly patients or patients with cardiac risk. Invest New Drugs 1990; 8:65-70.
13. American Joint Committee on Cancer: Manual for staging of cancer. 3rd Edition. Philadelphia: J.B. Lippincott, 1988.
14. Hermans, Bonenkamp JJ, Boon MC, et al: Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomised trials. J Clin Oncol 1993; 11:1441-1447.
15. Earle CC, Maroun JA: Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 1999; 35:1059-1064.
16. Mari E, Floriani I, Tinazzi A, et al: Efficacy of adjuvant chemotherapy after curative resections for gastric cancer: a meta-analysis of published randomized trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 2000; 11:837-843.
17. Janunger K-G, Haffstrom L, Glimelius B: Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002; 168:597-608.
18. Grau JJ, Martin M, Fuster J, et al: Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer. J Surg Oncol 2003; 82:234-240.
19. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345:725-730.
20. Chang HM, Jung KH, Kim TY, et al: A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer. Ann Oncol 2002; 13:1779-1785.
21. Tsavaris N, Tentas K, Kosmidis P, et al: A randomized trial comparing fluorouracil, epirubicin, and mitomycin C with no treatment in operable gastric cancer. Chemotherapy, 1996; 42:220-226.
22. Kasakura Y, Phan A, Ajani J: Adjuvant therapy for resected gastric carcinoma: Surg Oncol Clin N Am 2002; 11:431-444.
23. Vanhoefer U, Rougier P, Wilke H, et al: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 2000; 18:2648-2657.